Upcoming EventBioProcess International USA Conference & Exhibition, September 21-25

More than 20 leading biopharmaceutical companies announced yesterday the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as antimicrobial resistance, or AMR, continues to grow and take lives. In a statement, BIO President and CEO Dr. Michelle McMurry-Heath said, “Even as the world’s scientists work tirelessly to fight COVID-19, we must not ease up on our battle against antimicrobial resistance.”

Click here to learn more.

Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

AMRI

AMRI

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio

Burrell College of Osteopathic Medicine

Burrell College of Osteopathic Medicine